← Leaderboards
Satish K Srivastava
University Of Texas Medical Br Galveston
$10,741,277
Attributed
$11,632,026
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $787.1K · FY2005–18$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$11,632,026 · 5
By mechanism
R01$7,555,439 · 4
R37$4,076,587 · 1
Top collaborators
- Kota Venkata Ramana4 shared
Most similar at University Of Texas Medical Br Galveston
Same institution · by research overlap
- Kota Venkata Ramana$4,229,574
- Yogesh Chandra Awasthi$6,761,569
Others in their field
Top investigators on “Oxidative Stress”
- Leonardo Trasande · New York University School Of Medicine$57,471,048
- Rosalind J Wright · Icahn School Of Medicine At Mount Sinai$36,739,005
- Claire Gmachl · Princeton University$34,397,540
- Akram N Alshawabkeh · Northeastern University$31,872,089
- Gervasio A Lamas · Mount Sinai Medical Center (Miami Beach)$31,629,832
- Robert O Wright · Brigham And Women'S Hospital$30,479,869
Research focus
Oxidative StressAldehyde ReductaseHyperglycemiaCytokinePreventInhibitor/AntagonistSignal TransductionMediatingLeadOxidation-ReductionMolecularAldehydesReactive Oxygen SpeciesBaseLipidsInflammatoryIn VivoGlutathionePathway InteractionsHomeostasisInflammatory MarkerDiabetes MellitusFunctional DisorderAffect
Grant awards (35)
Role of Aldose Reductase in Diabetic Complications$436,658
R01 · FY2018 · DK · contact PI
Role of Aldose Reductase in Diabetic Complications$436,658
R01 · FY2017 · DK · contact PI
Role of Aldose Reductase in Diabetic Complications$436,658
R01 · FY2016 · DK · contact PI
Chemoprevention of Colorectal Cancer by Aldose Reductase Inhibition$311,976
R01 · FY2016 · CA · contact PI
Role of Aldose Reductase in Diabetic Complications$471,524
R01 · FY2015 · DK · contact PI
Chemoprevention of Colorectal Cancer by Aldose Reductase Inhibition$311,976
R01 · FY2015 · CA · contact PI
Chemoprevention of Colorectal Cancer by Aldose Reductase Inhibition$302,210
R01 · FY2014 · CA · contact PI
Role of Aldose Reductase in Diabetic Complications$333,282
R37 · FY2013 · DK · contact PI
Chemoprevention of Colorectal Cancer by Aldose Reductase Inhibition$310,970
R01 · FY2013 · CA · contact PI
Role of Aldose Reductase in Diabetic Complications$384,840
R37 · FY2012 · DK · contact PI
Chemoprevention of Colorectal Cancer by Aldose Reductase Inhibition$303,925
R01 · FY2012 · CA · contact PI
Role of Aldose Reductase in Diabetic Complications$384,840
R37 · FY2011 · DK · contact PI
Chemoprevention of Colorectal Cancer by Aldose Reductase Inhibition$303,925
R01 · FY2011 · CA · contact PI
Role of Aldose Reductase in Diabetic Complications$388,727
R37 · FY2010 · DK · contact PI
Chemoprevention of Colorectal Cancer by Aldose Reductase Inhibition$313,325
R01 · FY2010 · CA · contact PI
Role of Aldose Reductase in Diabetic Complications$85,000
R37 · FY2010 · DK · contact PI
Role of Aldose Reductase in Diabetic Complications$404,920
R37 · FY2009 · DK · contact PI
Chemoprevention of Colorectal Cancer by Aldose Reductase Inhibition$313,325
R01 · FY2009 · CA · contact PI
Role of Aldose Reductase in Diabetic Complications$370,109
R37 · FY2008 · DK · contact PI
Chemoprevention of Colorectal Cancer by Aldose Reductase Inhibition$313,325
R01 · FY2008 · CA · contact PI
Role of Aldose Reductase in Diabetic Complications$332,006
R37 · FY2007 · DK · contact PI
Metabolic Studies in Normal and Cataractous Lenses$363,746
R01 · FY2006 · EY · contact PI
Role of Aldose Reductase in Diabetic Complications$341,922
R37 · FY2006 · DK · contact PI
Metabolic Studies in Normal and Cataractous Lenses$372,500
R01 · FY2005 · EY
Role of Aldose Reductase in Diabetic Complications$350,150
R37 · FY2005 · DK
Metabolic Studies in Normal and Cataractous Lenses$372,500
R01 · FY2004 · EY
Role of Aldose Reductase in Diabetic Complications$350,641
R37 · FY2004 · DK
Metabolic Studies in Normal and Cataractous Lenses$372,500
R01 · FY2003 · EY
Role of Aldose Reductase in Diabetic Complications$350,150
R37 · FY2003 · DK
Metabolic Studies in Normal and Cataractous Lenses$372,500
R01 · FY2002 · EY
ALDOSE REDUCTASE AND DIABETIC COMPLICATIONS$214,929
R01 · FY2002 · DK
METABOLIC STUDIES IN NORMAL AND CATARACTOUS LENSES$256,938
R01 · FY2001 · EY
ALDOSE REDUCTASE AND DIABETIC COMPLICATIONS$208,668
R01 · FY2001 · DK
METABOLIC STUDIES IN NORMAL AND CATARACTOUS LENSES$252,110
R01 · FY2000 · EY
ALDOSE REDUCTASE AND DIABETIC COMPLICATIONS$202,593
R01 · FY2000 · DK